HEXO Corp. (TSE:HEXO) Given Consensus Rating of “Hold” by Brokerages

Shares of HEXO Corp. (TSE:HEXO) have been assigned a consensus recommendation of “Hold” from the eight research firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and three have issued a hold recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is C$2.35.

A number of analysts have commented on HEXO shares. BMO Capital Markets reaffirmed a “market perform” rating and set a C$2.00 target price on shares of HEXO in a report on Monday, November 1st. CIBC dropped their price target on shares of HEXO from C$2.00 to C$0.80 and set an “underperform” rating for the company in a research report on Thursday, December 16th. ATB Capital dropped their price target on shares of HEXO from C$1.50 to C$0.80 in a research report on Thursday, December 16th. dropped their price target on shares of HEXO from C$2.00 to C$1.00 in a research report on Thursday, December 16th. Finally, Jefferies Financial Group dropped their price target on shares of HEXO from C$1.35 to C$0.67 and set a “hold” rating for the company in a research report on Thursday, January 27th.

Shares of HEXO traded down C$0.03 during mid-day trading on Friday, hitting C$0.77. 2,952,183 shares of the company traded hands, compared to its average volume of 2,743,202. The company has a debt-to-equity ratio of 38.33, a quick ratio of 0.28 and a current ratio of 1.02. The stock has a 50-day moving average price of C$0.86 and a two-hundred day moving average price of C$2.07. HEXO has a 1 year low of C$0.58 and a 1 year high of C$10.59. The stock has a market cap of C$311.99 million and a price-to-earnings ratio of -0.54.

(Ad)

It’s scientific breakthroughs like this that give investors like you the chance to get in early on companies that will revolutionize the world…

And you may only get one opportunity in life to invest in something this big…

About HEXO

HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name.

Featured Stories

Analyst Recommendations for HEXO (TSE:HEXO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in HEXO right now?

Before you consider HEXO, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and HEXO wasn’t on the list.

While HEXO currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Source link

Leave a Reply

Your email address will not be published.